---
$id: https://graph.org.ai/products/commodity/51111830
$type: Product
source: UNSPSC
code: "51111830"
title: "Abiraterone"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Abiraterone

**UNSPSC Code**: 51111830
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-androgen with the molecular formula C24H31NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G819A456D0, chemically known as 17-(3-pyridyl)androsta-5,16-dien-3beta-ol but generally known as abiraterone, which bears US NIH Compound Identifier 132971. Abiraterone most often appears in forms base and acetate. European Medicines Agency schedules Abiraterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07361MIG. The term ABIRATERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10 No. 3, 1996, List 36). ABIRATERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule abiraterone under HS 29372900 and SITC 54153. As of Q4 2014, ABIRATERONE remains the US FDA Preferred Term for this commodity. Abiraterone bears US NLM identifiers UMLS ID C0754011 and NCI Concept Code C77333. SMILES: OC1CC2=CCC3C(C2(CC1)C)CCC1(C3CC=C1C1CCCNC1)C.

